Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

PRC1 influences skin stem cell development by both turning genes on and off, affecting hair growth and skin cell types.

A protein called sFRP4 can slow down hair regrowth.

Peficitinib can turn human fibroblasts into cells that help grow hair.

Activating TERT in mice skin boosts hair growth by waking up hair follicle stem cells.

Cancer cells often have more copies of TERT and TERC genes, which helps them grow and could affect patient outcomes.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Sirolimus effectively reduces lesions and improves quality of life in Blue Rubber Bleb Nevus Syndrome with manageable side effects.

Sex steroids influence skin appendage function and neoplasm development, with changes in AR and ERalpha in certain gland neoplasms.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

DHT deficiency may disrupt rat epididymis function by affecting estrogen receptors.

Sirolimus and propranolol may reduce abnormal cell growth and improve lymphatic malformations in children.

Boosting certain cell signals can prevent hair loss from chemotherapy and radiation.

Vismodegib effectively treats advanced basal cell carcinoma but requires careful management of serious side effects.

ERK activation spreads between cells, influencing cell division and wound healing.

Erlotinib can cause unusual hair growth, like long eyelashes and facial hair.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

Recombinant human epidermal growth factor is versatile, effective, and safe for long-term skin and mucosal treatments.

Activating liver X receptors can reduce fibrosis by stopping certain immune cells from releasing harmful proteins.

Blocking mTORC1 activity with rapamycin could help increase hair pigmentation and growth, potentially reversing gray hair.

Deleting vitamin D and calcium receptors in skin cells increases skin cancer risk by reducing DNA repair and stress response.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Adding TERT and BMI1 to certain skin cells can improve their ability to create hair follicles in mice.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

RSPO1 could help create new diabetes treatments by increasing pancreatic β cells.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.